More or less IV fluid for sepsis blood pressure support
Part of Infections clinical trials.
This trial compares whether giving more liberal or more restricted IV fluids helps stabilize people with sepsis and low blood pressure. It may help your team choose a fluid strategy that better supports blood flow to your organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been enrolled in one of these earlier studies: ARISE FLUIDS, CLASSIC, CLOVERS, or EVIS
- You have (or had) a suspected or confirmed infection
- At the time of enrollment you had low blood pressure (systolic under 100) or low mean arterial pressure (under 65)
- You had an elevated lactate level (at least 2.0 mmol/L)
- You needed blood-pressure medicine (vasopressors) to reach target perfusion goals
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational fluid called VBI-S to see if it can help raise blood pressure in people with septic shock who are not responding to standard fluids. You may qualify if you have severe infection and low blood pressure that needs medication support.
This study tests if giving fewer fluids (other than the fluids to keep blood pressure up) can help people recover from septic shock. It compares a reduced fluid strategy to the usual care in the ICU.
This study looks at how the body responds to extra fluids in patients with severe infections (septic shock) who are on a breathing machine. It may help doctors better manage fluid treatment in the ICU.
This trial tests whether using specific safety signals can prevent harm from too much fluid given during septic shock. It may help guide doctors to stop fluids at the right time.
This study tests a computer software that helps doctors decide how much fluid to give patients in septic shock. It aims to improve blood pressure and oxygen delivery without causing fluid overload.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.